Akero Therapeutics
AKRO
AKRO
157 hedge funds and large institutions have $1.4B invested in Akero Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 54
52% less capital invested
Capital invested by funds: $2.9B → $1.4B (-$1.5B)
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
157
Holding in Top 10
2
Calls
$42M
Puts
$12.4M
Top Buyers
| 1 | +$83.9M | |
| 2 | +$61.1M | |
| 3 | +$47.9M | |
| 4 |
Morgan Stanley
New York
|
+$39.1M |
| 5 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$16.4M |
Top Sellers
| 1 | -$64.1M | |
| 2 | -$39.4M | |
| 3 | -$38.9M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$28.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$26M |